Bill · H.R. 2041· House(119-HR-2041)
Hidden Fee Disclosure Act of 2025
- Introduced
- 3/11/2025
- Last activity
- 3/11/2025 — Referred to the House Committee on Education and Workforce.
- Sponsored by
- Joe Courtney
- Cosponsors
- - 0 - 1
- Introduced
- In Committee
What this bill would do
The Hidden Fee Disclosure Act of 2025 aims to amend the Employee Retirement Income Security Act of 1974. This legislation seeks to clarify and strengthen disclosure requirements for employer-sponsored health plan service providers. It specifically targets pharmacy benefit management services and third party administration services. The bill mandates more detailed reporting of compensation, including fees, rebates, and discounts. These disclosures must be provided annually to responsible plan fiduciaries.
Yes· 3 of 9
Does this lower the price of prescription medicines?+5
By requiring disclosure of rebates and spread pricing, the bill aims to increase transparency in drug pricing.
Does this give people more protection from unfair business practices?+5
The bill enhances consumer protection by mandating transparency in health plan service fees.
Does this make what the government does easier for the public to see?+4
The bill significantly increases financial transparency for health plan service providers.
The opposite
Would business owners be better off under this?-2
Increased administrative and disclosure burdens may impact business owners managing health plans.
Who it would affect, and how
Potential Positive Impacts for People
-
Increased Transparency for Health Plan Services: The bill expands the definition of services that require fee disclosure to include a wide range of areas such as plan design, claim repricing, insurance product selection, and pharmacy benefit management (Section 2).
-
Enhanced Oversight of Pharmacy Benefit Management: Pharmacy benefit managers must disclose all compensation, including rebates, price concessions, and "spread pricing" (Section s3(b)(1)). This provides visibility into how much money is being made through the drug pricing process.
-
Detailed Annual Financial Reporting: Service providers must provide an annual written report to plan fiduciaries detailing gross and net spending on drugs, as well as any costs collected from pharmacies in excess of contracted rates (Section 3(b)(2)).
-
Greater Visibility into Third Party Administration: Providers of third party administration services must disclose the amount and form of rebates, discounts, or savings fees received from providers and facilities (Section 3(b)(1)).
-
Protection of Personal Data: The bill includes specific privacy requirements to ensure that any disclosed information is consistent with HIPAA and other privacy regulations (Section 3(d)).
Potential Negative Impacts for People
- No specific negative impacts are explicitly stated in the text, though the bill includes a rule of construction noting that requiring disclosure does not make certain practices permissible under Federal law (Section 3(e)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Reduces Prescription Drug Costs+5Reduces Private Insurance Premiums+3
- Governance And Ideology
- Improves Government Transparency+4Improves Privacy Rights+2Increases Federal Power+1
- Economy And Finance
- Improves Consumer Protection+5
- Demographic And Interest Groups
- Good For Middle Class Households+3Good For Low Income Households+2Good For Business Owners-2
- Education And Technology
- Improves Data Privacy+2
- 3/11/2025
- Referred to the House Committee on Education and Workforce.
- 1 Cosponsor added.
- Introduced in House
Erin HouchinRepublican · Indiana